Table 1 Patient characteristics
Characteristics | Patients (n = 99) | |
|---|---|---|
Sex, n (%) | Male | 87 (12.1) |
Female | 12 (87.9) | |
Age, n (%) | ≥ 65 years | 69 (69.7) |
< 65 years | 30 (30.3) | |
ECOG PS, n (%) | 0 | 22 (22.2) |
1 | 77 (77.8) | |
Primary subsite, n (%) | Pyriform sinus | 63 (63.6) |
Posterior wall | 17 (17.2) | |
Postcricoid region | 19 (19.2) | |
pT stage, n (%) | T1–2 | 12 (12.1) |
T3–4 | 87 (87.9) | |
pN stage, n (%) | N0–2a | 27 (27.3) |
N2b–2c | 19 (19.2) | |
N3b | 53 (53.5) | |
Smoking history (pack-years), n (%) | ≧ 10 | 77 (77.8) |
< 10 | 22 (22.2) | |
Habitual alcohol consumption, n (%) | No | 16 (16.2) |
Yes | 83 (83.8) | |
positive margin, n (%) | No | 88 (88.9) |
Yes | 11 (11.1) | |
ENE, n (%) | No | 46 (46.5) |
Yes | 53 (53.5) | |
Adjuvant therapy, n (%) | None | 45 (45.5) |
RT alone | 31 (31.3) | |
Cisplatin + RT | 13 (13.1) | |
Carboplatin + RT | 5 (5.1) | |
FP + RT | 2 (2.0) | |
S-1 | 3 (3.0) |